Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis.
Lipoprotein(a) (Lp[a]) continues to be a controversial molecule regarding its role in human vascular disease. Although the physiologic role of this molecule is still unclear, novel discoveries within the last few years have suggested numerous mechanisms whereby Lp(a) may contribute to atherosclerosis and its complications in human subjects. These effects may differentially occur in vascular tissue and circulating blood compartments. A complex interplay between tissue-specific effects is probably more relevant to the pathogenicity of this molecule than one single effect alone. This review briefly describes the structure of Lp(a) in relation to its biochemical function, summarizing the current literature on various pathophysiologic mechanisms of Lp(a)-induced vascular disease and the role of cell and tissue-specific effects in promoting atherogenesis and thrombosis.
Deb
Arjun
A
Division of Cardiovascular Diseases and Molecular Medicine Program, Mayo Clinic, Rochester, Minnesota 55905, USA.
Caplice
Noel M
NM
D001161:Arteriosclerosis / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology*; D001777:Blood Coagulation / Q000502:physiology; D004730:Endothelium, Vascular / Q000503:physiopathology; D006801:Humans; D017270:Lipoprotein(a) / Q000502:physiology*; D013925:Thromboplastin / Q000502:physiology; D013927:Thrombosis / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology*
D017270:Lipoprotein(a); D013925:Thromboplastin